Draft guidance on management of rolling reviews for drug submissions: Fees (English, HTML)

View metadata and access the original English HTML file: Draft guidance on management of rolling reviews for drug submissions: Fees.

Format

HTML

Access

file-only

Publisher-reported update

2023-09-01

Sponsors will be issued an invoice for the full fee related to examining the NDS or SNDS once Health Canada has accepted the submission for review and issued the screening acceptance letter.

Access original file